Willdan (WLDN) Form 144 Details: Option Exercise Sale Scheduled 08/18/2025
Rhea-AI Filing Summary
Willdan Group, Inc. (WLDN) Form 144 notice: An insider proposes to sell 5,082 common shares acquired by stock option exercise on 08/18/2025, with an aggregate market value reported as $570,904.77. The filing shows 14,665,087 shares outstanding and lists the planned sale on 08/18/2025 through Morgan Stanley Smith Barney on the NASDAQ. The filer states payment was made in cash and represents there is no undisclosed material adverse information. The filing also discloses recent sales by Thomas D. Brisbin during May 2025 totaling 30,000+ shares across three transactions with gross proceeds reported for each sale.
Positive
- Transparent disclosure of the broker, exact share count (5,082), acquisition method (stock option exercise), and aggregate market value ($570,904.77)
- Includes prior insider sales over the past three months with dates and gross proceeds, aiding investor visibility
Negative
- Insider share sales were executed in May 2025 (totaling multiple transactions) which may be interpreted negatively by some investors
- No 10b5-1 plan date is provided in the filing, so plan-based safe-harbor cannot be confirmed from this document
Insights
TL;DR: Routine insider sale via exercised options; disclosure provides clear timing, amounts, and broker details.
The filing documents a sale of 5,082 shares acquired by option exercise and scheduled for sale the same day, with full cash payment. The filing is compliant in detailing broker, approximate sale date, shares outstanding, and past three months of insider sales. For investors, this is a standard liquidity event rather than a disclosed operational development. The amounts disclosed are explicit, enabling precise calculation of share dilution or insider disposition if combined with other filings.
TL;DR: Required insider reporting completed; representation about lack of material nonpublic information is included.
The signee affirms no material nonpublic information exists and the notice references Rule 144 compliance and potential Rule 10b5-1 planning. That statement and the explicit past-sales table improve transparency. There is no mention of a 10b5-1 plan adoption date in the filing, so readers cannot confirm pre-specified trading-plan protection from insider trading claims from this document alone.